<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-20T11:16:38Z</responseDate><request verb="GetRecord" identifier="oai:wakespace.lib.wfu.edu:10339/90766" metadataPrefix="dim">https://wakespace.lib.wfu.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:null:10339/90766</identifier><datestamp>2026-09-02T09:28:52Z</datestamp><setSpec>com_10339_14934</setSpec><setSpec>col_10339_38132</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Qadri, Saman</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2018-05-24T08:36:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2019-05-23T08:30:10Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2018</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://wakespace.lib.wfu.edu/handle/10339/90766</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative &#xd;
motor neuron &#xd;
disorder &#xd;
that causes muscular atrophy&#xd;
. Though researchers have established a correlation between &#xd;
race and survival, it is still not well understood whether there are differences in severity at &#xd;
time of diagnosis and subsequently, interventions &#xd;
chosen by ALS patients. &#xd;
The &#xd;
goal&#xd;
of this &#xd;
study  was  to  understand  whether  disease  se&#xd;
verity  at  time  of  diagnosis &#xd;
and  interventions &#xd;
chosen   by   ALS   patients   were   different   when   stratified   by   self&#xd;
-&#xd;
identified   race. &#xd;
A &#xd;
retrospective chart review was conducted on 49&#xd;
African American ALS patients and 137 &#xd;
Caucasian ALS patients. &#xd;
70.10% of Caucasian patients used &#xd;
noninvasive ventilation (&#xd;
NIV&#xd;
)&#xd;
compared  to  55.10%  of  African  Americans  (p&#xd;
-&#xd;
value=  0.015).  However,  5.22%  of &#xd;
Caucasian patients used &#xd;
tracheostomy with invasive ve&#xd;
ntilation (&#xd;
TIV&#xd;
)&#xd;
compared to 16.33% &#xd;
of African American patients (p&#xd;
-&#xd;
value= 0.018). After accounting for baseline severity and &#xd;
caregiver availability, the significance of differences in NIV (p&#xd;
-&#xd;
value= 0.057) and TIV (p&#xd;
-&#xd;
value=0.109) use decreased. After adjust&#xd;
ing for baseline seve&#xd;
rity and caregiver, PEG use &#xd;
approached &#xd;
significance  (p&#xd;
-&#xd;
value  0.068). &#xd;
After  adjusting  for  SES,  NIV  differences  are &#xd;
statistically significant (p&#xd;
-&#xd;
value= 0.045) while PEG further borders significance (p&#xd;
-&#xd;
value= &#xd;
0.055).&#xd;
Therefore, s&#xd;
elf&#xd;
-&#xd;
ident&#xd;
ified race plays a&#xd;
n important&#xd;
role in &#xd;
differences in rates of &#xd;
NIV &#xd;
and PEG&#xd;
.&#xd;
This research is the first of its kind to analyze social determinants of health and &#xd;
intervention rates. &#xd;
Future research should &#xd;
utilize a larger sample size and &#xd;
explore patients’ &#xd;
per&#xd;
spectives on their ALS diagnosis and interventions&#xd;
.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Wake Forest University</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">ALS</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">health disparities</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">NIV rates</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Racial Disparities in Intervention Rates in Individuals with ALS</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeChair" lang="en_US">Cartwright, Michael S</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Milligan, Carolanne E.</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Langefeld, Carl D.</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Caress, James B.</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline" lang="en_US">Health Disparities in Neuroscience-related Disorders – MS</dim:field>
   <dim:field mdschema="thesis" element="embargo" qualifier="terms" lang="en_US">2019-05-23</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>